Literature DB >> 22045076

Preventing contrast-induced nephropathy in patients undergoing primary PCI.

Shea Hogan1, Hitinder S Gurm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22045076

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN： 1042-3931            Impact factor:   2.022


× No keyword cloud information.
  3 in total

1.  Prevention of contrast-induced nephropathy with prostaglandin E1 in high-risk patients undergoing percutaneous coronary intervention.

Authors:  Wen-Hua Li; Dong-Ye Li; Wen-Hao Qian; Jia-Li Liu; Tong-Da Xu; Hong Zhu; Hai-Yan He
Journal:  Int Urol Nephrol       Date:  2014-02-26       Impact factor: 2.370

2.  Growth differentiation factor-15 levels and the risk of contrast induced nephropathy in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A retrospective observation study.

Authors:  Ling Sun; Xuejun Zhou; Jianguang Jiang; Xuan Zang; Xin Chen; Haiyan Li; Haitao Cao; Qingjie Wang
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

3.  Dysregulation of HULC promotes contrast-induced nephropathy (CIN) via regulating signaling pathway of miRNA-512 and prostaglandin E1 (PGE1).

Authors:  Liang Zhang; Pan Li; Bi-Li Zhang; Man-Li Yu; Rong-Liang Xu; Hong Wu; Shao-Ping Chen
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.